Literature DB >> 12732609

Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice.

Yuichiro Adachi1, Yoshihiko Saito, Ichiro Kishimoto, Masaki Harada, Koichiro Kuwahara, Nobuki Takahashi, Rika Kawakami, Michio Nakanishi, Yasuaki Nakagawa, Keiji Tanimoto, Yoshitomo Saitoh, Shinji Yasuno, Satoru Usami, Masaru Iwai, Masatsugu Horiuchi, Kazuwa Nakao.   

Abstract

BACKGROUND: Angiotensin II plays a prominent role in the progression of heart failure after acute myocardial infarction (AMI). Although both angiotensin type 1 (AT1) and type 2 (AT2) receptors are known to be present in the heart, comparatively little is known about the latter. We therefore examined the role played by AT2 receptors in post-AMI heart failure. METHODS AND
RESULTS: In wild-type mice subjected to AMI by coronary artery ligation, AT2 receptor immunoreactivity is upregulated in the infarct and border areas. Among AT2 receptor-null (-/-) mice, the 7-day survival rate after AMI was significantly lower than among wild-type mice (43% versus 67%; P<0.05). All sham-operated animals of both genotypes survived through the study. Ventricular mRNA levels for brain natriuretic peptide were elevated in both genotypes 24 hours after coronary occlusion, with levels in AT2-/- significantly higher than in wild-type mice, as were their lung weights, and histological examination revealed marked pulmonary congestion in the AT2-/- mice. Cardiac function was significantly decreased in AT2-/- mice 2 days after AMI.
CONCLUSIONS: AT2 receptor deficiency exacerbates short-term death rates and heart failure after experimental AMI in mice. The AT2 receptor may thus exert a protective effect on the heart after AMI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732609     DOI: 10.1161/01.CIR.0000072763.98069.B4

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.

Authors:  Gerry T M Wagenaar; Rozemarijn M A Sengers; El Houari Laghmani; Xueyu Chen; Melissa P H A Lindeboom; Anton J M Roks; Gert Folkerts; Frans J Walther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

Review 3.  AT2 receptors targeting cardiac protection post-myocardial infarction.

Authors:  Elena Kaschina; Dilyara Lauer; Patrick Schmerler; Thomas Unger; U Muscha Steckelings
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

4.  Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.

Authors:  E Bruce; V Shenoy; A Rathinasabapathy; A Espejo; A Horowitz; A Oswalt; J Francis; A Nair; T Unger; M K Raizada; U M Steckelings; C Sumners; M J Katovich
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 5.  Angiotensin II receptors and drug discovery in cardiovascular disease.

Authors:  Chiranjib Dasgupta; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-12-13       Impact factor: 7.851

6.  Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.

Authors:  Ivson Bezerra da Silva; Dayane Aparecida Gomes; Natalia Alenina; Michael Bader; Robson Augusto Dos Santos; Maria Luiza M Barreto-Chaves
Journal:  Heart Vessels       Date:  2017-12-07       Impact factor: 2.037

Review 7.  Angiotensin II type-2 receptor-specific effects on the cardiovascular system.

Authors:  Ying Li; Xiao-Hui Li; Hong Yuan
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

8.  Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.

Authors:  Gerry T M Wagenaar; El Houari Laghmani; Melissa Fidder; Rozemarijn M A Sengers; Yvonne P de Visser; Louwe de Vries; Rick Rink; Anton J M Roks; Gert Folkerts; Frans J Walther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

Review 9.  Inhibiting the renin-angiotensin system with ACE Inhibitors or ARBs after MI.

Authors:  Maryse Palardy; Anique Ducharme; Eileen O'Meara
Journal:  Curr Heart Fail Rep       Date:  2007-12

10.  Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarction.

Authors:  Jiang Xu; Ying Sun; Oscar A Carretero; Liping Zhu; Pamela Harding; Edward G Shesely; Xiangguo Dai; Nour-Eddine Rhaleb; Edward Peterson; Xiao-Ping Yang
Journal:  Hypertension       Date:  2014-04-14       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.